10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2010 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2010 10-K (Filed: Feb 25, 2011) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | |
| Cash flows from operating activities: | |||
| Net income | $ 4,627 | 4,605 | 4,052 |
| Depreciation and amortization | 1,017 | 1,049 | 1,073 |
| Stock-based compensation expense | 353 | 284 | 262 |
| Deferred income taxes | (167) | 47 | (137) |
| Property, plant and equipment impairments | 118 | 21 | 59 |
| Dividend received from equity investee | 0 | 110 | 8 |
| Other items, net | 140 | 111 | 244 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (210) | (36) | 65 |
| Inventories | 153 | (134) | (59) |
| Other current assets | 36 | (3) | 15 |
| Accounts payable | 142 | 71 | 95 |
| Accrued income taxes | (656) | (142) | 14 |
| Other accrued liabilities | 152 | 320 | (30) |
| Deferred revenue | 82 | 33 | 327 |
| Net cash provided by operating activities | 5,787 | 6,336 | 5,988 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (580) | (530) | (672) |
| Cash paid for acquisitions, net of cash acquired | 0 | 0 | (56) |
| Purchases of marketable securities | (14,602) | (12,418) | (10,345) |
| Proceeds from sales of marketable securities | 10,485 | 8,252 | 6,762 |
| Proceeds from maturities of marketable securities | 642 | 1,443 | 1,018 |
| Other | (97) | 51 | 128 |
| Net cash used in investing activities | (4,152) | (3,202) | (3,165) |
| Cash flows from financing activities: | |||
| Repurchases of common stock | (3,786) | (3,208) | (2,268) |
| Repayment of debt | 0 | (1,000) | (2,000) |
| Net proceeds from issuance of debt | 2,471 | 1,980 | 991 |
| Net proceeds from issuance of common stock in connection with the Company's equity award programs | 80 | 171 | 155 |
| Other | 3 | 33 | 49 |
| Net cash used in financing activities | (1,232) | (2,024) | (3,073) |
| Increase (decrease) in cash and cash equivalents | 403 | 1,110 | (250) |
| Cash and cash equivalents at beginning of period | 2,884 | 1,774 | |
| Cash and cash equivalents at end of period | 3,287 | 2,884 | 1,774 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |